- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13:30 | Glenmark Pharmaceuticals Receives U.S. FDA Approval for Progesterone Vaginal Inserts, 100 mg | 344 | PR Newswire | ELMWOOD PARK, N.J., April 9, 2026 /PRNewswire/ -- Glenmark Pharmaceuticals Limited (Glenmark) has received final approval from the United States Food & Drug Administration... ► Artikel lesen | |
| 06:35 | Glenmark Pharma gets USFDA nod for Progesterone Vaginal Inserts | 5 | capitalmarket.com | ||
| 02.04. | Glenmark goes direct with new US Ryaltris marketing plan as it drops partner model | 5 | FiercePharma | ||
| 01.04. | Glenmark Pharmaceuticals Announces Strategic Shift to Direct Commercialization and Distribution of RYALTRIS in the U.S., Significantly Expanding Its Innovative Portfolio | 97 | PR Newswire | RYALTRIS® is Glenmark's first innovative product introduced into the U.S. market
ELMWOOD PARK, N.J., April 1, 2026 /PRNewswire/ -- Glenmark Pharmaceuticals Inc.... ► Artikel lesen | |
| 31.03. | Glenmark Pharmaceuticals Canada Inc. Launches Men's GLN-Minoxidil 5% w/w Topical Aerosol Foam in Canadian Retail | 289 | PR Newswire | GLN-Minoxidil Men's 5% Foam is a topical treatment formulated with 5% minoxidil, a widely used and clinically established ingredient for supporting hair regrowth in men. The fast-drying, unscented aerosol... ► Artikel lesen | |
| 24.03. | Glenmark Pharma may outperform amid market correction; technicals turn positive: Ruchit Jain | 4 | Times of India | ||
| 21.03. | Glenmark Pharma launches GLIPIQ (semaglutide) in India for Type 2 Diabetes at lower cost | 3 | capitalmarket.com | ||
| 19.03. | Glenmark secures USFDA nod for OTC Nasal Spray; launches Generic Milnacipran tablets in US | 3 | capitalmarket.com | ||
| GLENMARK PHARMACEUTICALS Aktie jetzt für 0€ handeln | |||||
| 16.03. | Glenmark Pharma gains as US arm to launch Potassium Phosphates Injection | 2 | capitalmarket.com | ||
| 05.03. | FDA gives Glenmark thumbs up for first 'true' generic version of GSK's asthma inhaler Flovent | 4 | FiercePharma | ||
| 04.03. | Glenmark Gets FDA Nod for Fluticasone Propionate Inhalation Generic | 2 | Contract Pharma | ||
| 04.03. | Glenmark Pharmaceuticals: Glenmark Specialty SA Receives U.S. FDA Approval for Fluticasone Propionate Inhalation Aerosol USP, 44 mcg per actuation, with 180-Day Competitive Generic Therapy Exclusivity | 223 | PR Newswire | ELMWOOD PARK, N.J., March 4, 2026 /PRNewswire/ -- Glenmark Specialty SA (Glenmark) has received final approval by the United States Food & Drug Administration (U.S.... ► Artikel lesen | |
| 04.03. | Glenmark Pharma secures USFDA nod for Fluticasone Propionate Inhalation Aerosol | 7 | capitalmarket.com | ||
| 04.03. | Glenmark Wins US FDA Approval For Inhalation Therapy Medicine With 180 Day Generic Exclusivity | 4 | The Free Press Journal | ||
| 27.02. | Glenmark Pharma's USA arm to market Sodium Phosphate injection in April 2026 | 3 | capitalmarket.com | ||
| 26.02. | Glenmark Pharmaceuticals Ltd gains for third straight session | 2 | capitalmarket.com | ||
| 22.01. | EQS-News: AcuCort AB: AcuCort schließt kommerzielle Vereinbarung mit Glenmark Pharmaceuticals für Deutschland und fünf weitere europäische Länder | 498 | EQS Group (DE) | EQS-News: AcuCort AB
/ Schlagwort(e): Joint Venture/Produkteinführung
AcuCort schließt kommerzielle Vereinbarung mit Glenmark Pharmaceuticals für Deutschland und fünf weitere... ► Artikel lesen | |
| 22.01. | AcuCort Signs Glenmark Deal To Market Zeqmelit In Six European Countries | 6 | RTTNews | ||
| 22.01. | ACUCORT AB: AcuCort signs commercial agreement with Glenmark Pharmaceuticals for Germany and five additional European countries | 4 | Cision News | ||
| 23.12.25 | Glenmark Pharma's US arm launches Epinephrine Injection in American market | 6 | capitalmarket.com |
1 2 3 Weiter >>
46 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SINOPHARM | 2,278 | -2,69 % | Reed Sinopharm Exhibitions (RSE): PCHi 2026: World's Largest Cosmetics Ingredients Exhibition Opens in Hangzhou | 860+ exhibitors from 26 countries and regions across 70,000 sqmClose to 50 new product launches, including global and China debuts295 product submissions and 19 engineer nominations for the... ► Artikel lesen | |
| CSPC PHARMA | 0,982 | -4,20 % | CSPC PHARMA (01093): UPDATE ANNOUNCEMENT - CONNECTED TRANSACTION IN RELATION TO THE DISPOSAL OF 30.0704% EQUITY INTEREST IN THE TARGET COMPANY | ||
| WUXI BIOLOGICS | 3,815 | -1,29 % | WuXi Biologics Reports Record 2025 Annual Results | Revenue increased 16.7% YoY to RMB 21.8 billion, and revenue from continuous operations grew over 20% YoY
IFRS gross profit margin expanded to 46.0% (+500 bps... ► Artikel lesen | |
| SHANGHAI FOSUN PHARMACEUTICAL | 2,248 | +0,99 % | Fosun Pharma Announces Change of Chief Financial Officer | ||
| GEDEON RICHTER | 32,780 | -0,06 % | Gedeon Richter Plc.: Side-by-Side Conference Hosts Close to 800 Participants in Malta to Advance Women's Health Care | Gedeon Richter's Side-by-Side Conference on Advancing Women's Health brought together Healthcare practitioners from 40 countries for a dynamic two-day exchange on March 26-27, making it the largest... ► Artikel lesen | |
| DR REDDYS | 11,200 | 0,00 % | DR REDDYS LABORATORIES LTD - 6-K, Report of foreign issuer | ||
| ASPEN PHARMACARE | 6,650 | 0,00 % | ASPEN PHARMACARE HOLDINGS LIMITED - Distribution of circular to shareholders and notice of general meeting | ||
| SHANGHAI PHARMACEUTICALS | 1,370 | +3,01 % | CLSA Raises Shanghai Pharmaceuticals TP to HKD15.2, Rating Outperform | ||
| LUYE PHARMA | 0,304 | -4,40 % | LUYE PHARMA (02186): VOLUNTARY ANNOUNCEMENT FIRST SUBJECT ENROLLED IN THE PHASE II CLINICAL TRIAL IN CHINA OF THE GROUP'S INNOVATIVE DRUG LY03020 | ||
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP | 0,155 | +1,31 % | SIHUAN PHARM (00460): VOLUNTARY ANNOUNCEMENT - LICENSING AND SUPPLY AGREEMENT REACHED BETWEEN XUANZHU BIOPHARM AND BOSTON ONCOLOGY FOR BIREOCICLIB AND ... | ||
| CHINA RESOURCES PHARMACEUTICAL | 0,685 | 0,00 % | HSI Closes at 24,788, Up 37 pts; HSTI Closes at 4,649, Down 40 pts; HANSOH PHARMA Up over 7%; ICBC, BANK OF CHINA, GOFINTECH QUANT, GUANGDONG INV, CHINARES PHARMA Hit New Highs; Market Turnover Rises | ||
| HANSOH PHARMACEUTICAL | 4,231 | +1,22 % | BOCOM International Lowers Hansoh Pharmaceutical TP to HKD44.5 as Last Year's Results Exceeded Expectations | ||
| CHINA SHINEWAY PHARMACEUTICAL GROUP | 1,100 | +1,85 % | China Shineway Pharmaceutical Group Limited Full Year Income Rises | ||
| KALBE FARMA | 0,052 | +15,56 % | KLBF profit rises 13% in 2025, prepares IDR 500 billion buyback: Strong export lifts KLBF's net profit 13% to ... | ||
| BAYER | 40,450 | -0,07 % | EQS-PVR: Bayer Aktiengesellschaft: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Bayer Aktiengesellschaft
Bayer Aktiengesellschaft: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
02.04.2026... ► Artikel lesen |
GLENMARK PHARMACEUTICALS LTD gehört der Branche Pharma an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GLENMARK PHARMACEUTICALS LTD finden Sie auf Wallstreet Online.